{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:45:21Z","timestamp":1787168721871,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL081572"],"award-info":[{"award-number":["R01HL081572"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK116603"],"award-info":[{"award-number":["R01DK116603"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00394-021-02732-8","type":"journal-article","created":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T12:02:31Z","timestamp":1636200151000},"page":"1245-1254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Magnesium intake is inversely associated with risk of non-alcoholic fatty liver disease among American adults"],"prefix":"10.1007","volume":"61","author":[{"given":"Liping","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Brockman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Shikany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5078-2010","authenticated-orcid":false,"given":"Ka","family":"Kahe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,6]]},"reference":[{"key":"2732_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64:73\u201384. https:\/\/doi.org\/10.1002\/hep.28431","journal-title":"Hepatology"},{"key":"2732_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cgh.2011.03.020","volume":"9","author":"ZM Younossi","year":"2011","unstructured":"Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M (2011) Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 9:524\u2013530. https:\/\/doi.org\/10.1016\/j.cgh.2011.03.020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2732_CR3","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/hep.28123","volume":"62","author":"ZM Younossi","year":"2015","unstructured":"Younossi ZM, Otgonsuren M, Henry L, Venkatesan C, Mishra A, Erario M, Hunt S (2015) Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology 62:1723\u20131730. https:\/\/doi.org\/10.1002\/hep.28123","journal-title":"Hepatology"},{"key":"2732_CR4","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","volume":"17","author":"Z Younossi","year":"2019","unstructured":"Younossi Z, Stepanova M, Ong JP, Jacobson IM, Bugianesi E, Duseja A, Eguchi Y, Wong VW, Negro F, Yilmaz Y, Romero-Gomez M, George J, Ahmed A, Wong R, Younossi I, Ziayee M, Afendy A (2019) Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates. Clin Gastroenterol Hepatol 17:748-755.e3. https:\/\/doi.org\/10.1016\/j.cgh.2018.05.057","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2732_CR5","first-page":"276","volume":"7","author":"L Patrick","year":"2002","unstructured":"Patrick L (2002) Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. Altern Med Rev 7:276\u2013291","journal-title":"Altern Med Rev"},{"key":"2732_CR6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/hep.26672","volume":"59","author":"AL Birkenfeld","year":"2014","unstructured":"Birkenfeld AL, Shulman GI (2014) Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology 59:713\u2013723. https:\/\/doi.org\/10.1002\/hep.26672","journal-title":"Hepatology"},{"key":"2732_CR7","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0026-0495(96)90156-0","volume":"45","author":"FR Kandeel","year":"1996","unstructured":"Kandeel FR, Balon E, Scott S, Nadler JL (1996) Magnesium deficiency and glucose metabolism in rat adipocytes. Metabolism 45:838\u2013843. https:\/\/doi.org\/10.1016\/S0026-0495(96)90156-0","journal-title":"Metabolism"},{"key":"2732_CR8","doi-asserted-by":"publisher","first-page":"E745","DOI":"10.1152\/ajpendo.1995.269.4.E745","volume":"269","author":"TW Balon","year":"1995","unstructured":"Balon TW, Gu JL, Tokuyama Y, Jasman AP, Nadler JL (1995) Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am J Physiol 269:E745-752. https:\/\/doi.org\/10.1152\/ajpendo.1995.269.4.E745","journal-title":"Am J Physiol"},{"key":"2732_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.nut.2017.01.009","volume":"38","author":"JBS Morais","year":"2017","unstructured":"Morais JBS, Severo JS, de Alencar GRR, de Oliveira ARS, Cruz KJC, Marreiro DDN, Freitas B, de Carvalho CMR, Martins M, Frota KMG (2017) Effect of magnesium supplementation on insulin resistance in humans: a systematic review. Nutrition 38:54\u201360. https:\/\/doi.org\/10.1016\/j.nut.2017.01.009","journal-title":"Nutrition"},{"key":"2732_CR10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/fcp.12387","volume":"32","author":"S Sohrabipour","year":"2018","unstructured":"Sohrabipour S, Sharifi MR, Sharifi M, Talebi A, Soltani N (2018) Effect of magnesium sulfate administration to improve insulin resistance in type 2 diabetes animal model: using the hyperinsulinemic-euglycemic clamp technique. Fundam Clin Pharmacol 32:603\u2013616. https:\/\/doi.org\/10.1111\/fcp.12387","journal-title":"Fundam Clin Pharmacol"},{"key":"2732_CR11","doi-asserted-by":"publisher","first-page":"C1371","DOI":"10.1152\/ajpcell.1992.262.6.C1371","volume":"262","author":"AM Freedman","year":"1992","unstructured":"Freedman AM, Mak IT, Stafford RE, Dickens BF, Cassidy MM, Muesing RA, Weglicki WB (1992) Erythrocytes from magnesium-deficient hamsters display an enhanced susceptibility to oxidative stress. Am J Physiol 262:C1371-1375. https:\/\/doi.org\/10.1152\/ajpcell.1992.262.6.C1371","journal-title":"Am J Physiol"},{"key":"2732_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/jir.S136742","volume":"11","author":"FH Nielsen","year":"2018","unstructured":"Nielsen FH (2018) Magnesium deficiency and increased inflammation: current perspectives. J Inflamm Res 11:25\u201334. https:\/\/doi.org\/10.2147\/jir.S136742","journal-title":"J Inflamm Res"},{"key":"2732_CR13","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1017\/S1368980018000642","volume":"21","author":"W Li","year":"2018","unstructured":"Li W, Zhu X, Song Y, Fan L, Wu L, Kabagambe EK, Hou L, Shrubsole MJ, Liu J, Dai Q (2018) Intakes of magnesium, calcium and risk of fatty liver disease and prediabetes. Public Health Nutr 21:2088\u20132095. https:\/\/doi.org\/10.1017\/S1368980018000642","journal-title":"Public Health Nutr"},{"key":"2732_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/2050640617707863","volume":"6","author":"A Eshraghian","year":"2018","unstructured":"Eshraghian A, Nikeghbalian S, Geramizadeh B, Malek-Hosseini SA (2018) Serum magnesium concentration is independently associated with non-alcoholic fatty liver and non-alcoholic steatohepatitis. United Eur Gastroenterol J 6:97\u2013103. https:\/\/doi.org\/10.1177\/2050640617707863","journal-title":"United Eur Gastroenterol J"},{"key":"2732_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1753-4887.2011.00465.x","volume":"70","author":"A Rosanoff","year":"2012","unstructured":"Rosanoff A, Weaver CM, Rude RK (2012) Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutr Rev 70:153\u2013164. https:\/\/doi.org\/10.1111\/j.1753-4887.2011.00465.x","journal-title":"Nutr Rev"},{"key":"2732_CR16","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/0895-4356(88)90080-7","volume":"41","author":"GD Friedman","year":"1988","unstructured":"Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR Jr, Liu K, Savage PJ (1988) CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 41:1105\u20131116. https:\/\/doi.org\/10.1016\/0895-4356(88)90080-7","journal-title":"J Clin Epidemiol"},{"key":"2732_CR17","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/S0002-8223(21)01299-2","volume":"91","author":"A McDonald","year":"1991","unstructured":"McDonald A, Van Horn L, Slattery M, Hilner J, Bragg C, Caan B, Jacobs D Jr, Liu K, Hubert H, Gernhofer N, Betz E, Havlik D (1991) The CARDIA dietary history: development, implementation, and evaluation. J Am Diet Assoc 91:1104\u20131112","journal-title":"J Am Diet Assoc"},{"key":"2732_CR18","first-page":"15","volume":"4","author":"K Liu","year":"1994","unstructured":"Liu K, Slattery M, Jacobs D Jr, Cutter G, McDonald A, Van Horn L, Hilner JE, Caan B, Bragg C, Dyer A et al (1994) A study of the reliability and comparative validity of the cardia dietary history. Ethn Dis 4:15\u201327","journal-title":"Ethn Dis"},{"key":"2732_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1559-4564.2006.05702.x","volume":"1","author":"K He","year":"2006","unstructured":"He K, Song Y, Belin RJ, Chen Y (2006) Magnesium intake and the metabolic syndrome: epidemiologic evidence to date. J Cardiometab Syndr 1:351\u2013355. https:\/\/doi.org\/10.1111\/j.1559-4564.2006.05702.x","journal-title":"J Cardiometab Syndr"},{"key":"2732_CR20","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1161\/CIRCULATIONAHA.105.588327","volume":"113","author":"K He","year":"2006","unstructured":"He K, Liu K, Daviglus ML, Morris SJ, Loria CM, Van Horn L, Jacobs DR, Savage PJ (2006) Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 113:1675\u20131682. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.588327","journal-title":"Circulation"},{"key":"2732_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/oxfordjournals.aje.a009849","volume":"149","author":"FB Hu","year":"1999","unstructured":"Hu FB, Stampfer MJ, Rimm E, Ascherio A, Rosner BA, Spiegelman D, Willett WC (1999) Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 149:531\u2013540. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a009849","journal-title":"Am J Epidemiol"},{"key":"2732_CR22","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3945\/ajcn.111.020719","volume":"95","author":"FP Sijtsma","year":"2012","unstructured":"Sijtsma FP, Meyer KA, Steffen LM, Shikany JM, Van Horn L, Harnack L, Kromhout D, Jacobs DR Jr (2012) Longitudinal trends in diet and effects of sex, race, and education on dietary quality score change: the coronary artery risk development in young adults study. Am J Clin Nutr 95:580\u2013586. https:\/\/doi.org\/10.3945\/ajcn.111.020719","journal-title":"Am J Clin Nutr"},{"key":"2732_CR23","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/liv.13603","volume":"38","author":"LB VanWagner","year":"2018","unstructured":"VanWagner LB, Khan SS, Ning H, Siddique J, Lewis CE, Carr JJ, Vos MB, Speliotes E, Terrault NA, Rinella ME, Lloyd-Jones DM, Allen NB (2018) Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: the CARDIA cohort study. Liver Int 38:706\u2013714. https:\/\/doi.org\/10.1111\/liv.13603","journal-title":"Liver Int"},{"key":"2732_CR24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.atherosclerosis.2014.05.962","volume":"235","author":"LB VanWagner","year":"2014","unstructured":"VanWagner LB, Ning H, Lewis CE, Shay CM, Wilkins J, Carr JJ, Terry JG, Lloyd-Jones DM, Jacobs DR Jr, Carnethon MR (2014) Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the coronary artery risk development in young adults study. Atherosclerosis 235:599\u2013605. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.05.962","journal-title":"Atherosclerosis"},{"key":"2732_CR25","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/oby.21767","volume":"25","author":"LB VanWagner","year":"2017","unstructured":"VanWagner LB, Terry JG, Chow LS, Alman AC, Kang H, Ingram KH, Shay C, Lewis CE, Bryan RN, Launer LJ, Jeffrey Carr J (2017) Nonalcoholic fatty liver disease and measures of early brain health in middle-aged adults: the CARDIA study. Obesity 25:642\u2013651. https:\/\/doi.org\/10.1002\/oby.21767","journal-title":"Obesity"},{"key":"2732_CR26","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1053\/j.gastro.2017.08.012","volume":"153","author":"LB VanWagner","year":"2017","unstructured":"VanWagner LB, Ning H, Allen NB, Ajmera V, Lewis CE, Carr JJ, Lloyd-Jones DM, Terrault NA, Siddique J (2017) Alcohol use and cardiovascular disease risk in patients with nonalcoholic fatty liver disease. Gastroenterology 153:1260-1272.e3. https:\/\/doi.org\/10.1053\/j.gastro.2017.08.012","journal-title":"Gastroenterology"},{"key":"2732_CR27","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.2214\/ajr.06.0992","volume":"188","author":"Y Kodama","year":"2007","unstructured":"Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK, Vauthey JN, Charnsangavej C (2007) Comparison of CT methods for determining the fat content of the liver. Am J Roentgenol 188:1307\u20131312. https:\/\/doi.org\/10.2214\/ajr.06.0992","journal-title":"Am J Roentgenol"},{"key":"2732_CR28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1751-2980.2008.00331.x","volume":"9","author":"MD Zeng","year":"2008","unstructured":"Zeng MD, Fan JG, Lu LG, Li YM, Chen CW, Wang BY, Mao YM (2008) Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J Dig Dis 9:108\u2013112. https:\/\/doi.org\/10.1111\/j.1751-2980.2008.00331.x","journal-title":"J Dig Dis"},{"key":"2732_CR29","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003384","volume":"5","author":"PJ Schreiner","year":"2016","unstructured":"Schreiner PJ, Jacobs DR Jr, Wong ND, Kiefe CI (2016) Twenty-five year secular trends in lipids and modifiable risk factors in a population-based biracial cohort: the coronary artery risk development in young adults (CARDIA) study, 1985\u20132011. J Am Heart Assoc 5:e003384. https:\/\/doi.org\/10.1161\/JAHA.116.003384","journal-title":"J Am Heart Assoc"},{"key":"2732_CR30","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/00008483-198911000-00003","volume":"9","author":"DR Jacobs Jr","year":"1989","unstructured":"Jacobs DR Jr, Hahn LP, Haskell WL, Pirie P, Sidney S (1989) Validity and reliability of short physical activity history: cardia and the minnesota heart health program. J Cardiopulm Rehabil 9:448\u2013459","journal-title":"J Cardiopulm Rehabil"},{"key":"2732_CR31","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/oby.21023","volume":"23","author":"JP Reis","year":"2015","unstructured":"Reis JP, Allen N, Gunderson EP, Lee JM, Lewis CE, Loria CM, Powell-Wiley TM, Rana JS, Sidney S, Wei G (2015) Excess body mass index-and waist circumference-years and incident cardiovascular disease: the CARDIA study. Obesity 23:879\u2013885. https:\/\/doi.org\/10.1002\/oby.21023","journal-title":"Obesity"},{"key":"2732_CR32","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1210\/jcem-25-10-1375","volume":"25","author":"V Herbert","year":"1965","unstructured":"Herbert V, Lau KS, Gottlieb CW, Bleicher SJ (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375\u20131384. https:\/\/doi.org\/10.1210\/jcem-25-10-1375","journal-title":"J Clin Endocrinol Metab"},{"key":"2732_CR33","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.2337\/dc18-1287","volume":"41","author":"MP Bancks","year":"2018","unstructured":"Bancks MP, Carnethon MR, Jacobs DR, Launer LJ, Reis JP, Schreiner PJ, Shah RV, Sidney S, Yaffe K, Yano Y (2018) Fasting glucose variability in young adulthood and cognitive function in middle age: the coronary artery risk development in young adults (CARDIA) study. Diabetes Care 41:2579\u20132585. https:\/\/doi.org\/10.2337\/dc18-1287","journal-title":"Diabetes Care"},{"key":"2732_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0076-6879(86)29064-3","volume":"129","author":"GR Warnick","year":"1986","unstructured":"Warnick GR (1986) Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol 129:101\u2013123. https:\/\/doi.org\/10.1016\/0076-6879(86)29064-3","journal-title":"Methods Enzymol"},{"key":"2732_CR35","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499\u2013502. https:\/\/doi.org\/10.1093\/clinchem\/18.6.499","journal-title":"Clin Chem"},{"key":"2732_CR36","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3390\/nu9070667","volume":"9","author":"I Cantero","year":"2017","unstructured":"Cantero I, Abete I, Monreal JI, Martinez JA, Zulet MA (2017) Fruit fiber consumption specifically improves liver health status in obese subjects under energy restriction. Nutrients 9:667. https:\/\/doi.org\/10.3390\/nu9070667","journal-title":"Nutrients"},{"key":"2732_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.plipres.2012.10.004","volume":"52","author":"AK Leamy","year":"2013","unstructured":"Leamy AK, Egnatchik RA, Young JD (2013) Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. Prog Lipid Res 52:165\u2013174. https:\/\/doi.org\/10.1016\/j.plipres.2012.10.004","journal-title":"Prog Lipid Res"},{"issue":"Suppl","key":"2732_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/jgh.12244","volume":"28","author":"JG Fan","year":"2013","unstructured":"Fan JG, Cao HX (2013) Role of diet and nutritional management in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 28(Suppl):81\u201387. https:\/\/doi.org\/10.1111\/jgh.12244","journal-title":"J Gastroenterol Hepatol"},{"key":"2732_CR39","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/MCO.0b013e328357f747","volume":"15","author":"T Pacana","year":"2012","unstructured":"Pacana T, Sanyal AJ (2012) Vitamin E and non-alcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 15:641\u2013648. https:\/\/doi.org\/10.1097\/MCO.0b013e328357f747","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2732_CR40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/MCO.0000000000000469","volume":"21","author":"S Chiu","year":"2018","unstructured":"Chiu S, Mulligan K, Schwarz J-M (2018) Dietary carbohydrates and fatty liver disease: de novo lipogenesis. Curr Opin Clin Nutr Metab Care 21:277\u2013282. https:\/\/doi.org\/10.1097\/MCO.0000000000000469","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2732_CR41","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.2337\/dc06-1014","volume":"29","author":"RM van Dam","year":"2006","unstructured":"van Dam RM, Hu FB, Rosenberg L, Krishnan S, Palmer JR (2006) Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in US black women. Diabetes Care 29:2238\u20132243. https:\/\/doi.org\/10.2337\/dc06-1014","journal-title":"Diabetes Care"},{"key":"2732_CR42","first-page":"190","volume-title":"Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride","author":"Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference","year":"1997","unstructured":"Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference (1997) The national academies collection: reports funded by national institutes of health. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. National Academies Press, Washington (DC), pp 190\u2013249"},{"key":"2732_CR43","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/jgh.13857","volume":"33","author":"VW Wong","year":"2018","unstructured":"Wong VW, Chan WK, Chitturi S, Chawla Y, Dan YY, Duseja A, Fan J, Goh KL, Hamaguchi M, Hashimoto E, Kim SU, Lesmana LA, Lin YC, Liu CJ, Ni YH, Sollano J, Wong SK, Wong GL, Chan HL, Farrell G (2018) Asia-pacific working party on non-alcoholic fatty liver disease guidelines 2017-part 1: definition, risk factors and assessment. J Gastroenterol Hepatol 33:70\u201385. https:\/\/doi.org\/10.1111\/jgh.13857","journal-title":"J Gastroenterol Hepatol"},{"key":"2732_CR44","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/ijms20061351","volume":"20","author":"K Kostov","year":"2019","unstructured":"Kostov K (2019) Effects of magnesium deficiency on mechanisms of insulin resistance in type 2 diabetes: focusing on the processes of insulin secretion and signaling. Int J Mol Sci 20:1351. https:\/\/doi.org\/10.3390\/ijms20061351","journal-title":"Int J Mol Sci"},{"key":"2732_CR45","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.phrs.2016.06.019","volume":"111","author":"LE Simental-Mendia","year":"2016","unstructured":"Simental-Mendia LE, Sahebkar A, Rodriguez-Moran M, Guerrero-Romero F (2016) A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol Res 111:272\u2013282. https:\/\/doi.org\/10.1016\/j.phrs.2016.06.019","journal-title":"Pharmacol Res"},{"key":"2732_CR46","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s12011-016-0793-1","volume":"176","author":"JB Morais","year":"2017","unstructured":"Morais JB, Severo JS, Santos LR, de Sousa Melo SR, de Oliveira Santos R, de Oliveira AR, Cruz KJ, do Nascimento Marreiro D (2017) Role of magnesium in oxidative stress in individuals with obesity. Biol Trace Elem Res 176:20\u201326. https:\/\/doi.org\/10.1007\/s12011-016-0793-1","journal-title":"Biol Trace Elem Res"},{"key":"2732_CR47","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1039\/AN9952000859","volume":"120","author":"IB Afanas'ev","year":"1995","unstructured":"Afanas\u2019ev IB, Suslova TB, Cheremisina ZP, Abramova NE, Korkina LG (1995) Study of antioxidant properties of metal aspartates. Analyst 120:859\u2013862. https:\/\/doi.org\/10.1039\/AN9952000859","journal-title":"Analyst"},{"key":"2732_CR48","first-page":"9","volume":"10","author":"A Poongothai","year":"2004","unstructured":"Poongothai A, Vishnupriya S, Ragunadharao D (2004) Quantitative variation of superoxide dismutase levels in leukaemias. Indian J Hum Genet 10:9\u201312","journal-title":"Indian J Hum Genet"},{"key":"2732_CR49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5530\/jcdr.2014.1.4","volume":"5","author":"N Mahalle","year":"2014","unstructured":"Mahalle N, Garg MK, Mv K, Naik S (2014) Relation of magnesium with insulin resistance and inflammatory markers in subjects with known coronary artery disease. J Cardiovasc Dis Res 5:22\u201329. https:\/\/doi.org\/10.5530\/jcdr.2014.1.4","journal-title":"J Cardiovasc Dis Res"},{"key":"2732_CR50","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.2337\/dc10-0994","volume":"33","author":"DJ Kim","year":"2010","unstructured":"Kim DJ, Xun P, Liu K, Loria C, Yokota K, Jacobs DR Jr, He K (2010) Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care 33:2604\u20132610. https:\/\/doi.org\/10.2337\/dc10-0994","journal-title":"Diabetes Care"},{"key":"2732_CR51","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2337\/dc09-1402","volume":"33","author":"SA Chacko","year":"2010","unstructured":"Chacko SA, Song Y, Nathan L, Tinker L, de Boer IH, Tylavsky F, Wallace R, Liu S (2010) Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care 33:304\u2013310. https:\/\/doi.org\/10.2337\/dc09-1402","journal-title":"Diabetes Care"},{"key":"2732_CR52","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1007\/s00394-020-02206-3","volume":"59","author":"L Lu","year":"2020","unstructured":"Lu L, Chen C, Yang K, Zhu J, Xun P, Shikany JM, He K (2020) Magnesium intake is inversely associated with risk of obesity in a 30-year prospective follow-up study among American young adults. Eur J Nutr 59:3745\u20133753. https:\/\/doi.org\/10.1007\/s00394-020-02206-3","journal-title":"Eur J Nutr"},{"key":"2732_CR53","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.mayocp.2015.06.013","volume":"90","author":"EK Spengler","year":"2015","unstructured":"Spengler EK, Loomba R (2015) Recommendations for diagnosis, referral for liver biopsy, and treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Mayo Clin Proc 90:1233\u20131246. https:\/\/doi.org\/10.1016\/j.mayocp.2015.06.013","journal-title":"Mayo Clin Proc"},{"key":"2732_CR54","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1017\/S0007114519002769","volume":"123","author":"M Dorosti","year":"2020","unstructured":"Dorosti M, Heidarloo AJ, Bakhshimoghaddam F, Alizadeh M (2020) Whole-grain consumption and its effects on hepatic steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomised controlled clinical trial. Br J Nutr 123:328\u2013336. https:\/\/doi.org\/10.1017\/S0007114519002769","journal-title":"Br J Nutr"},{"key":"2732_CR55","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/aje\/kws448","volume":"178","author":"M Lazo","year":"2013","unstructured":"Lazo M, Hernaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E, Koteish A, Brancati FL, Clark JM (2013) Prevalence of nonalcoholic fatty liver disease in the United States: the third national health and nutrition examination survey, 1988\u20131994. Am J Epidemiol 178:38\u201345. https:\/\/doi.org\/10.1093\/aje\/kws448","journal-title":"Am J Epidemiol"},{"key":"2732_CR56","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/ajg.2014.134","volume":"110","author":"P Blais","year":"2015","unstructured":"Blais P, Husain N, Kramer JR, Kowalkowski M, El-Serag H, Kanwal F (2015) Nonalcoholic fatty liver disease is underrecognized in the primary care setting. Am J Gastroenterol 110:10\u201314. https:\/\/doi.org\/10.1038\/ajg.2014.134","journal-title":"Am J Gastroenterol"},{"key":"2732_CR57","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2337\/dc14-2852","volume":"38","author":"JC Bae","year":"2015","unstructured":"Bae JC, Lee WY, Yoon KH, Park JY, Son HS, Han KA, Lee KW, Woo JT, Ju YC, Lee WJ, Cho YY, Lee MK (2015) Improvement of nonalcoholic fatty liver disease with carnitine-orotate complex in type 2 diabetes (CORONA): a randomized controlled trial. Diabetes Care 38:1245\u20131252. https:\/\/doi.org\/10.2337\/dc14-2852","journal-title":"Diabetes Care"},{"key":"2732_CR58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/ajg.2010.299","volume":"106","author":"T Foster","year":"2011","unstructured":"Foster T, Budoff MJ, Saab S, Ahmadi N, Gordon C, Guerci AD (2011) Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis heart study randomized clinical trial. Am J Gastroenterol 106:71\u201377. https:\/\/doi.org\/10.1038\/ajg.2010.299","journal-title":"Am J Gastroenterol"},{"key":"2732_CR59","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/s41401-018-0194-4","volume":"40","author":"Y Yang","year":"2019","unstructured":"Yang Y, Zhao X, Xu H, Wang S, Pan Y, Wang S, Xu Q, Jiao R, Gu H, Kong L (2019) Magnesium isoglycyrrhizinate ameliorates high fructose-induced liver fibrosis in rat by increasing miR-375-3p to suppress JAK2\/STAT3 pathway and TGF-\u03b21\/Smad signaling. Acta Pharmacol Sin 40:879\u2013894. https:\/\/doi.org\/10.1038\/s41401-018-0194-4","journal-title":"Acta Pharmacol Sin"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-021-02732-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00394-021-02732-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-021-02732-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T12:12:22Z","timestamp":1647259942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00394-021-02732-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,6]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["2732"],"URL":"https:\/\/doi.org\/10.1007\/s00394-021-02732-8","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,6]]},"assertion":[{"value":"29 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no potential conflicts of interest regarding the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All participants in the Coronary Artery Risk Development in Young Adults Study provided written informed consent at each exam, with all procedures approved annually by institutional review boards at each field center and coordinating center. The ethical approval number for this study is 1907082670.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}